Valeo Financial Advisors, LLC Brainstorm Cell Therapeutics Inc. Transaction History

Valeo Financial Advisors, LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$3.01 - $4.01 $4,385 - $5,842	-1,457 Closed	0 $0
Q2 2020 Jul 20, 2020	BUY	$4.42 - $12.66 $3,978 - $11,394	900 Added 161.58%	1,457 $16,000
Q1 2019 Apr 12, 2019	BUY	$3.37 - $4.34 $1,877 - $2,417	557 New	557 $2,000

10.8M

160K

30.5K

Ticker BCLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 36,486,200
Market Cap $75.9M
Description
Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.